alexa HDACIs, An Alternative Therapeutic Approach Human Breast Cancer Treatment, In Vivo And In Vitro | 22715
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th World Congress on Cancer Science & Therapy
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Soha M H and Sultan A S
Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.035
Abstract
Breast cancer is the most common cause of cancer and the second most common cause of death in women worldwide. Despite major recent advances in therapy, more effective approaches to the treatment and prevention are necessary. Histone deacetylase inhibitors (HDACIs) provide an alternative therapeutic approach for the treatment of breast cancer. The therapeutic potential of HDACIs stems from their capacity to selectively induce apoptosis in tumor cells. HDACIs show promise as a single anti-cancer drugthat given the range of molecular and biological responses andhave a minimal toxicity to normal cells. In the present study, we investigated and compared the anticancer effects of two structurally distinct HDACIs, Vorinostat (SAHA) and Valproic Acid (VPA) respectively. In addition, we tested the effect of VPA/SAHA as a combination treatment, using T-47Dhuman breast cancer cell line. Anticancer effects of tested drugs were assessed by MTT assay, western blotting analysis of expression levels of p53, β-catenin and cyclin D1. In addition, apoptotic induction and morphological characteristics of T-47D breast cancer cells upon treatment with SAHA, VPA and combined treatment byboth drugs were performed.Furthermore, the antitumor effect of SAHA was investigatedbyimmunohistochemical analysis to detectcyclin Dl expression in tumor tissues of MNU-induced breast carcinoma in vivo. In vivo model, breast tumor size was decreased and nuclear localization of cyclin D1profoundly was changedupon SAHA treatment. In vitro, SAHAshowed a strong inhibitory effect on cyclin D1 expression compared to VPAinT-47D cells. In addition, HDACIs- treated T-47D cancer cells suppressed the expression level of oncogenic β-catenin expression and enhancedtotal p53 expression. Furthermore, SAHA,VPA and VPA/ SAHA combined treatments induced morphological changes, apoptosis induction and DNA fragmentations. These results suggest that the combination treatment of SAHA and/or VPA exerts significant antitumor activity and could be a promising therapeutic candidate for human breast cancer treatment.
Biography
Soha M H is a lecturer assistant at the biochemistry department-Faculty of Science - Alexandria University, Egypt.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version